Predicting response to vedolizumab therapy using mucosal transcriptomics in IBD patients

ABSTRACT: In this study we wanted to identify baseline predictors of successful vedolizumab therapy in patients with inflammatory bowel disease.

INSTRUMENT(S): Illumina HiSeq 4000

ORGANISM(S): Homo sapiens

SUBMITTER: Bram Verstockt 

PROVIDER: E-MTAB-7845 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress